The shareholders of the Company voted in favor of all proposals. A table containing tabulations of the votes casted is expected to be released in the coming days. CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology.
🌍 CureVac (CVAC) - Form 6-K Filing
Filing Date: 2022-06-22
Accepted: 2022-06-22 16:15:57
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: